PillRifampin
Brands: Rifadin Iv · Rifampin
3 active makers
soon
soon
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it3 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Mylan Institutional LLC | unknown | 1 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 1 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 1 | SUPPLYING |
| Sanofi-Aventis U.S. LLC | unknown | 1 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 7, 2022RECALLRecall (Class II): Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morg…
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing. — Recalling firm: Mylan Pharmaceuticals Inc — Nationwide in the USA
- Feb 17, 2021SHORTAGEDrug shortage: Rifampin Injection (Fresenius Kabi USA, LLC)
Rifampin Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Anti-Infective.
- Feb 17, 2021SHORTAGEDrug shortage: Rifampin Injection (Mylan Institutional, a Viatris Company)
Rifampin Injection — reported in shortage by Mylan Institutional, a Viatris Company. Therapeutic category: Anti-Infective.
- Feb 17, 2021SHORTAGEDrug shortage: Rifampin Injection (Sanofi-Aventis U.S. LLC)
Rifampin Injection — reported in shortage by Sanofi-Aventis U.S. LLC. Therapeutic category: Anti-Infective.
- Oct 7, 2019RECALLRecall (Class II): Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC …
Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product. — Recalling firm: Mylan Laboratories Limited (Sterile Products Division) — Nationwide in the USA
- Jun 4, 2015RECALLRecall (Class II): Rifampin for Injection, USP 600mg/vial in a 20mL vial, Rx only, Manufactured for Fresenius Kabi LLC 3 Corporate Drive, …
Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradation — Recalling firm: Fresenius Kabi USA, LLC — Nationwide,Hawaii, and Puerto Rico